×

Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins

  • US 20080220049A1
  • Filed: 08/17/2007
  • Published: 09/11/2008
  • Est. Priority Date: 12/05/2003
  • Status: Abandoned Application
First Claim
Patent Images

1. A sustained-release intraocular drug delivery system comprising:

  • a therapeutic component comprising an antiangiogenic polypeptide component; and

    a polymeric component associated with the therapeutic component to permit the therapeutic component to be released into the interior of an eye of an individual at a therapeutically effective dosage for a period of time after the drug delivery system is placed in the eye.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×